Trial Files is a biweekly newsletter with summaries of impactful RCTs that can be enjoyed with your morning coffee.
Ever wondered whether hydrocortisone actually influences patient outcomes for severe CAP? There's a trial for that :)
Check it out here!
https://t.co/cLvUDRqM5i
What were the top five randomized trials by @altmetric score from 2024? All were covered via our free https://t.co/odnPiaBT5A newsletter. And here is a brief thread to recap them 1/6 🧵
AI VIDEO is insanely taking over in 2024.
OpenAI just announced Sora , their first text-to-video model.
Here are 12 wild examples you can't afford to miss out on: 🧵
Trial Files is a biweekly newsletter with summaries of impactful RCTs that can be enjoyed with your morning coffee.
Ever wondered whether hydrocortisone actually influences patient outcomes for severe CAP? There's a trial for that :)
Check it out here!
https://t.co/cLvUDRqM5i
🚨TRIAL FILES🚨 is a newsletter from our lab co-led by @EmilyVBartsch. We provide bi-monthly summaries of RCTs relevant to GIM including a #TBT for seminal trials from years gone by. RCTs are found + summarized using PaperScrape, which our lab created and leverages chatgpt🤖 1/2
How does a Large Language Model like ChatGPT actually work?
Well, they are both amazingly simple and exceedingly complex at the same time.
Hold on to your butts, this is a deep dive ↓
Happy holidays! Introducing https://t.co/Ub3wgs1KVz, an AI-powered app that lets you chat with your data in English! RTutor uses Davinci (#ChatGPT’s sibling) to turn requests into R code, which is executed & results are shown instantly, available as a HTML report in seconds. 1/8
1/ On How Short Life Is
A few years ago, I was walking around in a blizzard in SoHo (New York). It was late, midnight, and it was beautiful.
Some friends, about 15 blocks away, called: "come over?"
It was late, it was cold, was tired, thought "maybe not worth it" but then...
My first #R01 as a #PI has been funded, so now we're looking for a #postdoc to join the project. Come and join the Ashbrook lab! I'm looking for someone with experience in #mitochondrial biology to join a large project. Please share! https://t.co/O5Emy77qoC
We are thrilled with the government’s support for the Scarborough Academy of Medicine and Integrated Health (#SAMIH) at #UTSC. More details on this milestone announcement coming soon. #UofT#ScarbTO@UofTNursing@uoftmedicine@uoftgro
Aduhelm (or aducanumab), beta-amyloid targeting antibody, is the first Alzheimer's disease therapy approved since 2003.
FDA’s Decision to Approve New Treatment for Alzheimer’s Disease https://t.co/vnrGh9tRWg